All In MedTech

FDA Clearance Tracker · P100044-S043

Propel

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 28, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 28, 2020

Approved

Time to decision

178 days

Received Sep 3, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100044-S043
Device name
Propel
Applicant location
Menlo Park, CA
Received
Sep 3, 2019
Decided
Feb 28, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100044

Device type

Device class
Class III

Every decision under product code OWO

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Steri-Tek, Smart World LLC, dba Steri-Tek, 48225 Lakeview Blvd., Fremont, CA 94538, which performs sterilization.

Source documents

Other decisions for Intersect Ent.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.